Human Genome Epidemiology Literature Finder
|
Records 1 - 25 (of 25 Records) |
| Query Trace: Ovarian Neoplasms and GSTT1[original query] |
|---|
| Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent results in cancer research. Fortschritte der Krebsforschung. Progre?s dans les recherches sur le cancer 1998 154 47-85. Hengstler J G, Arand M, Herrero M E, Oesch |
| Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 0 11 (2): 107-12. Howells R E, Holland T, Dhar K K, Redman C W, Hand P, Hoban P R, Jones P W, Fryer A A, Strange R |
| Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. Carcinogenesis 2001 Jan 22 (1): 67-72. Spurdle A B, Webb P M, Purdie D M, Chen X, Green A, Chenevix-Trench |
| Catechol-O-methyltransferase polymorphism is not associated with ovarian cancer risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000 Dec 9 (12): 1373-6. Goodman J E, Lavigne J A, Hengstler J G, Tanner B, Helzlsouer K J, Yager J |
| Glutathione S-transferase polymorphisms and risk of ovarian cancer: a HuGE review. Genetics in medicine : official journal of the American College of Medical Genetics 0 4 (4): 250-7. Coughlin Steven S, Hall Ingrid |
| Platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma: glutathione S-transferase genetic polymorphisms as predictive biomarkers of disease outcome. International journal of clinical oncology 2003 Jun 8 (3): 156-61. Medeiros Rui, Pereira Deolinda, Afonso Noémia, Palmeira Carlos, Faleiro Cristina, Afonso-Lopes Carlos, Freitas-Silva Margarida, Vasconcelos André, Costa Sandra, Osório Teresa, Lopes Carl |
| GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Jul 14 (7): 1823-7. Moore Lee E, Huang Wen-Yi, Chatterjee Nilanjan, Gunter Marc, Chanock Stephen, Yeager Meredith, Welch Bob, Pinsky Paul, Weissfeld Joel, Hayes Richard |
| Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival. Gynecologic oncology 2006 Feb 100 (2): 330-7. Beeghly A, Katsaros D, Chen H, Fracchioli S, Zhang Y, Massobrio M, Risch H, Jones B, Yu |
| Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients. Journal of cancer research and clinical oncology 2006 Aug 132 (8): 521-8. Morari Elaine Cristina, Lima Andre Bacellar Costa, Bufalo Natassia Elena, Leite Janaina Luisa, Granja Fabiana, Ward Laura Steri |
| The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. European journal of cancer (Oxford, England : 1990) 2007 Jan 43 (2): 283-90. Nagle Christina M, Chenevix-Trench Georgia, Spurdle Amanda B, Webb Penelope |
| Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Sep 17 (9): 2436-44. Gates Margaret A, Tworoger Shelley S, Terry Kathryn L, Titus-Ernstoff Linda, Rosner Bernard, De Vivo Immaculata, Cramer Daniel W, Hankinson Susan |
| Glutathione-S-transferase M1, T1 and P1 polymorphisms, and breast cancer risk, in BRCA1/2 mutation carriers. British journal of cancer 2008 Jun 98 (12): 2006-10. Kadouri L, Kote-Jarai Z, Hubert A, Baras M, Abeliovich D, Hamburger T, Peretz T, Eeles R |
| Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecologic oncology 2009 May 113 (2): 264-9. Kim Hee Seung, Kim Mi-Kyung, Chung Hyun Hoon, Kim Jae Weon, Park Noh Hyun, Song Yong Sang, Kang Soon Be |
| Glutathione S-transferase M1, T1, and P1 polymorphisms and ovarian cancer risk: a meta-analysis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010 Jul 20 (5): 732-7. Economopoulos Konstantinos P, Sergentanis Theodoros N, Vlahos Nikos |
| Pharmacogenomics of cisplatin-based chemotherapy in ovarian cancer patients of different ethnic origins. Pharmacogenomics 2011 Dec . Khrunin A, Ivanova F, Moisseev A, Khokhrin D, Sleptsova Y, Gorbunova V, Limborska S |
| [Association of polymorphisms in glutathione-S-transferase and DNA repair genes with ovarian cancer risk in the Russian population]. Genetika 2012 Jul 48 (7): 901-4. Khokhrin D V, Khrunin A V, Moiseev A A, Gorbunov V A, Limborskaia S |
| Polymorphisms of glutathione S-transferase Mu 1 (GSTM1), Theta 1 (GSTT1), and Pi 1 (GSTP1) genes and epithelial ovarian cancer risk. Disease markers 2012 33 (3): 155-9. Oliveira Cristiane, Lourenço Gustavo Jacob, Sagarra Regina Aparecida Martinho, Derchain Sophie Françoise Mauricette, Segalla José Getulio, Lima Carmen Silvia Pass |
| Lack of any association of GST genetic polymorphisms with susceptibility to ovarian cancer--a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (15): 6131-6. Han Li-Yuan, Liu Kui, Lin Xia-Lu, Zou Bao-Bo, Zhao Jin-Sh |
| Polymorphisms of glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) in ovarian cancer risk. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jun 35 (6): 5267-72. Jin Ying, Hao Zengpi |
| Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy. Journal of experimental & clinical cancer research : CR 2015 34 2. Tecza Karolina, Pamula-Pilat Jolanta, Kolosza Zofia, Radlak Natalia, Grzybowska E |
| Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer. Medical oncology (Northwood, London, England) 2016 Oct 33 (10): 112. Carron Juliana, Brito Angelo Borsarelli Carvalho, Torelli Ana Carolina Mourão, Oliveira Cristiane, Derchain Sophie Françoise Mauricette, Lima Carmen Silvia Passos, Lourenço Gustavo Jac |
| Polymorphic expression of glutathione transferases A1, M1, P1 and T1 in epithelial ovarian cancer: a Serbian case-control study. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 22 (1): 72-79. Pljesa Igor, Berisavac Milica, Simic Tatjana, Pekmezovic Tatjana, Coric Vesna, Suvakov Sonja, Stamatovic Ljiljana, Matic Marija, Gutic Bojana, Milenkovic Sanja, Pljesa-Ercegovac Marija, Savic-Radojevic A |
| Polymorphism of xenobiotic metabolizing gene and susceptibility of epithelial ovarian cancer with reference to organochlorine pesticides exposure. Experimental biology and medicine (Maywood, N.J.) 2019 Sep 1535370219878652. Sharma Tusha, Banerjee Basu D, Thakur Gaurav K, Guleria Kiran, Mazumdar Darsha |
| GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer. Clinical and translational science 2020 Dec . Ferracini Amanda Canato, Lopes-Aguiar Leisa, Lourenço Gustavo Jacob, Yoshida Adriana, Lima Carmen Silva Passos, Sarian Luis Otávio, Derchain Sophie, Kroetz Deanna L, Mazzola Priscila Ga |
| Individual effects of GSTM1 and GSTT1 polymorphisms on cervical or ovarian cancer risk: An updated meta-analysis. Frontiers in genetics 2023 1 13 1074570. Ye Jing, Mu Yi-Yang, Wang Jiong, He Xiao-Fe |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 05, 2023
- Content source: